ERBB2 and metastatic neoplasm: However, in the multivariable Cox model analysis, including age, type and number of metastases, de novo metastatic diseases, and period of care, ERBB2-low status was not significantly associated with OS (adjusted HR, 0.91; 95% CI, 0.82-1.01; P = .09) (Figure 3).